Collaboration : a key component of Domain’s DNA
We collaborate with pharmaceutical and biotech companies to advance GPCR drug discovery assets, not only in immuno-oncology, but also in the fields of CNS and rare diseases, in order to bring innovative solutions toward the clinic. Learn more about our latest collaborations here.
GPCR target for metabolic diseases
Precision Medicine and Immunotherapy of Sarcoma
Multi-target collaboration for rare diseases
CXCR4 biased agonist